Português
中文繁體中文EnglishFrançaisDeutsch日本語PortuguêsEspañolالعربيةРусскийBahasa IndonesiaไทยTiếng ViệtBahasa Melayu
Farmacia KESHAV KESHAV
Oferta do dia Popular Carrinho (0)
NEWS DETAIL

การวิเคราะห์เพิ่มเติมหลังการทดลอง ADMIRAL และ COMMODORE: ระยะเวลาการตอบสนองต่อการรักษาด้วยยา gilteritinib เพียงอย่างเดียวในผู้ป่วย AML ที่ดื้อต่อการรักษาและมีการกลายพันธุ์ของยีน FLT3 – aml-hub.com

Post hoc analysis of the ADMIRAL and COMMODORE trials: Timing of response with gilteritinib monotherapy in R/R FLT3m AML aml-hub.com

ข้อมูลทางการแพทย์

เนื้อหาบทความฉบับเต็ม

During the 66th ASH Annual Meeting and Exposition, Wang presented findings from a post hoc analysis of the ADMIRAL and COMMODORE trials investigating the timing of response to gilteritinib in patients with R/R FLT3m AML.

Produtos relacionados com este artigo

Estes produtos foram associados automaticamente a partir do titulo, resumo e conteudo do artigo.

Lucius Gilteritinib – Compre online

Lucius Gilteritinib – Compre online

EUR 277.33
O gefitinibe é um medicamento de prescrição aprovado para comercialização nos Estados Unidos em novembro de 2018. Ele tem como alvo a tirosina quinase 3 semelhante ao FMS (FLT3) e suas mutações (incluindo FLT3-ITD e FLT3-TKD, como D835Y, I836, etc.). Deve ser usado estritamente de acordo com as instruções do médico.
Ver produto
GILLIDX Gilteritinib 40mg

GILLIDX Gilteritinib 40mg

EUR 312.00
Gipritinibe é um potente inibidor oral e seletivo da tirosina quinase 3 semelhante ao FMS (FLT3). A aprovação do gipritinibe baseou-se no estudo clínico de fase III ADMIRAL, global, multicêntrico, aberto, randomizado e controlado, que recrutou 371 pacientes com leucemia mieloide aguda (LMA) recidivada ou refratária com mutações FLT3 detectadas no sangue ou na medula óssea. Esses pacientes foram randomizados na proporção de 2:1 para receber gipritinibe ou quimioterapia de resgate. O desfecho primário composto do estudo ADMIRAL foi a sobrevida global (SG) e a taxa de remissão completa (RC/RCi) com recuperação hematológica completa ou parcial. Os resultados deste estudo foram publicados no prestigiado periódico médico *The New England Journal of Medicine* (NEJM).
Ver produto

Perguntas frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Gilteritinib – Compre online GILLIDX Gilteritinib 40mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat